Drug General Information (ID: D0552)
  Drug Name
Edrophonium
  Drug Type Small molecule
  Drug Synonymous
EDR; Edrophonum; Edroponium; Reversol; Tensilon; EDROPHONIUM ION; Edrophone Chloride; Enlon Plus; ENLON-PLUS; Enlon (TN); Reversol (TN); Tensilon (TN); Ethyl-(3-hydroxyphenyl)-dimethylazanium; Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium; N-ethyl-3-hydroxy-N,N-dimethylanilinium; N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium; (3-hydroxyphenyl)dimethylethylammonium; 3-hydroxy-N,N-dimethyl-N-ethylanilinium
    Click to Show/Hide
  Disease Class 8C6Y: Myasthenia gravis
  Therapeutic Class Antidotes
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C10H16NO+
  InChI 1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1
  InChIKey VWLHWLSRQJQWRG-UHFFFAOYSA-O
  Canonical SMILES CC[N+](C)(C)C1=CC(=CC=C1)O
  External Link
Pubchem ID 3202
CAS Number 312-48-1
CHEBI ID 251408
TTD ID D0S5LH

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM037  Additive cholinergic effects
BM045  Additive neuromuscular blocking effects
BM049  Increased risk of atrioventricular block
BM051  Increased risk of bradycardia
BM081  Increased risk of ventricular arrhythmias
BM091  Antagonize the effect of cholinergic agents
  Relation Graph
 Full list of drugs interacting with Edrophonium
      Pharmacodynamic additive effects
   Additive cholinergic effects Drug Num:  9
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0516
 
Donepezil
 
C24H29NO3
 
3152 
Moderate    Inter Info   
[7], [8], [9]
D0054
 
Amifampridine
 
C5H7N3
 
5918 
Moderate    Inter Info   
[12], [13]
D0175
 
Bethanechol
 
C7H17N2O2+
 
2370 
Moderate    Inter Info   
[7], [8], [9]
D0546
 
Echothiophate (ophthalmic)
 
C9H23NO3PS+
 
10548 
Moderate    Inter Info   
[18]
D1122
 
Neostigmine
 
C12H19N2O2+
 
4456 
Moderate    Inter Info   
[7], [8], [9]
D0707
 
Galantamine
 
C17H21NO3
 
9651 
Moderate    Inter Info   
[7], [8], [9]
D1285
 
Physostigmine
 
C15H21N3O2
 
5983 
Moderate    Inter Info   
[7], [8], [9]
D1365
 
Pyridostigmine
 
C9H13N2O2+
 
4991 
Moderate    Inter Info   
[7], [8], [9]
D1418
 
Rivastigmine
 
C14H22N2O2
 
77991 
Moderate    Inter Info   
[7], [8], [9]
   Additive neuromuscular blocking effects Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1510
 
Succinylcholine
 
C14H30N2O4+2
 
5314 
Moderate    Inter Info   
[25], [26], [27], [7], [9]
   Increased risk of bradycardia Drug Num:  8
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1474
 
Siponimod
 
C29H35F3N2O3
 
44599207 
Major    Inter Info   
[1], [2]
D0031
 
Alectinib
 
C30H34N4O2
 
49806720 
Moderate    Inter Info   
[10], [11]
D0204
 
Brigatinib
 
C29H39ClN7O2P
 
68165256 
Moderate    Inter Info   
[14]
D0393
 
Crizotinib
 
C21H22Cl2FN5O
 
11626560 
Moderate    Inter Info   
[15], [16], [17]
D0661
 
Fingolimod
 
C19H33NO2
 
107970 
Moderate    Inter Info   
[19], [20]
D0868
 
Ivabradine
 
C27H36N2O5
 
132999 
Moderate    Inter Info   
[1], [21]
D0897
 
Lasmiditan
 
C19H18F3N3O2
 
11610526 
Moderate    Inter Info   
[22]
D1211
 
Ozanimod
 
C23H24N4O3
 
52938427 
Moderate    Inter Info   
[23]
   Increased risk of ventricular arrhythmias Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1569
 
Thalidomide
 
C13H10N2O4
 
5426 
Moderate    Inter Info   
[1], [15], [24]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of cholinergic agents Drug Num:  37
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0123
 
Atropine
 
C17H23NO3
 
174174 
Moderate    Inter Info   
[3]
D0160
 
Benzatropine
 
C21H25NO
 
1201549 
Moderate    Inter Info   
[3]
D0172
 
Betamethasone
 
C22H29FO5
 
9782 
Moderate    Inter Info   
[4], [5], [6]
D0183
 
Biperiden
 
C21H29NO
 
2381 
Moderate    Inter Info   
[3]
D0353
 
Clidinium
 
C22H26NO3+
 
2784 
Moderate    Inter Info   
[3]
D0370
 
Clozapine
 
C18H19ClN4
 
135398737 
Moderate    Inter Info   
[3]
D0424
 
Darifenacin
 
C28H30N2O2
 
444031 
Moderate    Inter Info   
[3]
D0508
 
Disopyramide
 
C21H29N3O
 
3114 
Moderate    Inter Info   
[3]
D0154
 
Belladonna
 
C34H42N2O4
 
265028 
Moderate    Inter Info   
[3]
D0215
 
Budesonide
 
C25H34O6
 
5281004 
Moderate    Inter Info   
[4], [5], [6]
D0392
 
Corticotropin
 
C207H308N56O58S
 
16132265 
Moderate    Inter Info   
[4], [5], [6]
D0436
 
Deflazacort
 
C25H31NO6
 
189821 
Moderate    Inter Info   
[4], [5], [6]
D0453
 
Dexamethasone
 
C22H29FO5
 
5743 
Moderate    Inter Info   
[4], [5], [6]
D0662
 
Flavoxate
 
C24H25NO4
 
3354 
Moderate    Inter Info   
[3]
D0759
 
Homatropine
 
C16H21NO3
 
5282593 
Moderate    Inter Info   
[3]
D1000
 
Mepenzolate
 
C21H26NO3+
 
4057 
Moderate    Inter Info   
[3]
D1031
 
Methscopolamine
 
C18H24NO4+
 
71183 
Moderate    Inter Info   
[3]
D1202
 
Oxybutynin
 
C22H31NO3
 
4634 
Moderate    Inter Info   
[3]
D1343
 
Procainamide
 
C13H21N3O
 
4913 
Moderate    Inter Info   
[3]
D1491
 
Solifenacin
 
C23H26N2O2
 
154059 
Moderate    Inter Info   
[3]
D1563
 
Tetracosactide
 
C136H210N40O31S
 
16133802 
Moderate    Inter Info   
[4], [5], [6]
D1607
 
Tolterodine
 
C22H31NO
 
443879 
Moderate    Inter Info   
[3]
D0671
 
Fludrocortisone
 
C21H29FO5
 
31378 
Moderate    Inter Info   
[4], [5], [6]
D0733
 
Glycopyrronium
 
C19H28NO3+
 
3494 
Moderate    Inter Info   
[3]
D0773
 
Hydrocortisone
 
C21H30O5
 
5754 
Moderate    Inter Info   
[4], [5], [6]
D0782
 
Hyoscyamine
 
C17H23NO3
 
154417 
Moderate    Inter Info   
[3]
D1041
 
Methylprednisolone
 
C22H30O5
 
6741 
Moderate    Inter Info   
[4], [5], [6]
D1332
 
Prednisolone
 
C21H28O5
 
5755 
Moderate    Inter Info   
[4], [5], [6]
D1334
 
Prednisone
 
C21H26O5
 
5865 
Moderate    Inter Info   
[4], [5], [6]
D1347
 
Procyclidine
 
C19H29NO
 
4919 
Moderate    Inter Info   
[3]
D1354
 
Propantheline
 
C23H30NO3+
 
4934 
Moderate    Inter Info   
[3]
D1371
 
Quinidine
 
C20H24N2O2
 
441074 
Moderate    Inter Info   
[3]
D1450
 
Scopolamine
 
C17H21NO4
 
3000322 
Moderate    Inter Info   
[3]
D1628
 
Triamcinolone
 
C21H27FO6
 
31307 
Moderate    Inter Info   
[4], [5], [6]
D1630
 
Triamcinolone (ophthalmic)
 
C21H27FO6
 
31307 
Moderate    Inter Info   
[4], [5], [6]
D1641
 
Trihexyphenidyl
 
C20H31NO
 
5572 
Moderate    Inter Info   
[3]
D1656
 
Trospium
 
C25H30NO3+
 
5284632 
Moderate    Inter Info   
[3]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
3 Product Information. Mestinon (pyridostigmine). ICN Pharmaceuticals Inc, Cost Mesa, CA.
4 Brunner NG, Namba T, Grob D "Corticosteroids in management of severe, generalized myasthenia gravis." Neurology 22 (1972): 603-10
5 Namba T "Corticotropin therapy in patients with myasthenia gravis." Arch Neurol 26 (1972): 144-50
6 Patten BM, Oliver KL, Engel WK "Adverse interaction between steroid hormones and anticholinesterase drugs." Neurology 24 (1974): 442-9
7 Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
8 Product Information. Cognex (tacrine). Parke-Davis, Morris Plains, NJ.
9 Product Information. Reminyl (galantamine) Janssen Pharmaceuticals, Titusville, NJ.
10 Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
11 Product Information. Alecensa (alectinib). Genentech, South San Francisco, CA.
12 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
13 Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
14 Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
15 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
16 Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
17 Canadian Pharmacists Association "e-CPS."
18 Product Information. Phospholine Iodide (echothiophate iodide ophthalmic). Wyeth Laboratories, Philadelphia, PA.
19 Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
20 FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
21 Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
22 Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
23 Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
24 Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
25 Freeman SE, Dawson RM "Tacrine: a pharmacological review." Prog Neurobiol 36 (1991): 257-77. [PMID: 1714613]
26 Heath ML "Donepezil and succinylcholine." Anaesthesia 58 (2003): 202. [PMID: 12562439]
27 Keeler JR "Interactions between nerve agent pretreatment and drugs commonly used in combat anesthesia." Mil Med 155 (1990): 527-33. [PMID: 2126852]